Products Categories
CAS No.: | 639089-54-6 |
---|---|
Name: | Tozasertib |
Article Data: | 4 |
Molecular Structure: | |
Formula: | C23H28N8OS |
Molecular Weight: | 464.594 |
Synonyms: | Cyclopropanecarboxylicacid N-[4-[[4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl]sulfanyl]phenyl]amide;MK 0457;VX 680; |
Density: | 1.4 g/cm3 |
PSA: | 127.37000 |
LogP: | 3.65210 |
IUPAC name: N-[4-[4-(4-Methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl] cyclopropanecarboxamide
Molecular Formula: C23H28N8OS
Molecular Weight: 464.59 g/mol
Index of Refraction: 1.69
Surface Tension: 78.9 dyne/cm
Density: 1.37 g/cm3
Following is the structure of Tozasertib (CAS NO.639089-54-6):
Tozasertib (CAS NO.639089-54-6) is a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth. It is mainly used to treat blood cancer, colon cancer and milk.
Tozasertib , its cas register number is 639089-54-6. It also can be called N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide ; MK 0457 ; and VX 680 . And its classification code is antineoplastic agents.